Ara
Toplam kayıt 10, listelenen: 1-10
Is there any advantage of treating partners in helicobacter pylori eradication?
(Hindawi Ltd, 2015)
Aim. We designed this trial to find answers to the following questions. (1) Does the success rate decrease in a country where HP prevalence is high? (2) Can we provide benefit by simultaneously treating the partners of ...
Relation of acanthosis nigricans to metabolic syndrome in overweight and obese women
(Mary Ann Liebert, Inc, 2014)
Objective: Insulin resistance appears to be the most likely underlying mechanism in metabolic syndrome. Acanthosis nigricans (AN) is an easily identifiable skin lesion and associated with insulin resistance. We aimed to ...
Alterations of thyroid volume and nodular size during and after pregnancy in a severe iodine-deficient area
(Wiley-Blackwell, 2014)
ObjectiveThe effects of pregnancy on thyroid nodules were investigated in a few number of studies. We aimed to evaluate the prevalence of thyroid nodules, the changes in size, volume and number of nodules during pregnancy ...
Comparison of levofloxacin- and moxifloxacin-based triple therapies with standard treatment in eradication of helicobacter pylori as first-line therapy
(Karger, 2014)
Aim: It is recommended that treatments that include clarithromycin should be avoided in eradication of Helicobacter pylori (HP) in cases where clarithromycin resistance is higher than 20%. We aimed to compare levofloxacin-and ...
The relation between carotid intima media thickness and serum osteoprotegerin levels in nonalcoholic fatty liver disease
(Mary Ann Liebert, Inc, 2014)
Aim: This study was designed to evaluate carotid intima media thickness (CIMT) and serum osteoprotegerin (OPG) levels in nonalcoholic fatty liver disease (NAFLD) in comparison to healthy controls and to investigate factors ...
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports
(Dustri-Verlag Dr Karl Feistle, 2015)
Background: Ertapenem is a broad-spectrum and long-acting carbapenem which is predominantly eliminated by the kidneys, and it requires dose adjustment in renal failure. Although it is known that excessive doses of ertapenem ...
Evaluation of para-and perirenal fat thickness and its association with metabolic disorders in polycystic ovary syndrome
(Amer Assoc Clinical Endocrinologists, 2015)
Objective: the aim of this study was to compare para-and perirenal fat (PFT) and subcutaneous abdominal fat (SFT) measurements between patients with polycystic ovary syndrome (PCOS) and control subjects and to assess the ...
Risk factors that increase insulin need in patients with gestational diabetes mellitus
(Mary Ann Liebert, Inc, 2018)
....
Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis
(Future Medicine Ltd, 2019)
Aim: To examine the PON1-L55M and-Q192R polymorphisms for polycystic ovary syndrome (PCOS) risk in relation with atherosclerosis risk markers. Methods: Blood samples were collected from 203 women (PCOS [n = 151], control ...
Genetic variations in OLR1 gene associated with PCOS and atherosclerotic risk factors
(Sage Publications, 2023)
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. The aim of this study was to investigate the association of oxidized low-density lipoprotein receptor 1 (OLR1) gene variations ...